TCL Archive NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction April 28, 2006
TCL Archive Shaky Start For FY11 Appropriations Cycle As Congress Feels Pressure to Cut Spending June 4, 2010
TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
TCL Archive NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network March 12, 2010
